|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Einstein-Rockefeller-CUNY Center for AIDS Research
|
5P30AI124414-02
|
$174,258
|
|
GOLDSTEIN, HARRIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
B7x in Cancer: Mechanisms and Therapies
|
1F30CA224931-01
|
$49,524
|
|
JOHN, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Paul Calabresi Career Development Award for Clinical Oncology (K12)
|
5K12CA132783-10
|
$508,802
|
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Investigating the role of Nol3 in normal and malignant hematopoiesis
|
1F30CA217063-01A1
|
$49,524
|
|
PISZCZATOWSKI, RICHARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-11
|
$290,592
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Developing a mobile application for circadian wellness in cancer patients
|
1R43CA236557-01A1
|
$221,237
|
$221,237
|
WALCH, OLIVIA
|
ARCASCOPE, LLC
|
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
$39,254
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
$612,939
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
$442,560
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$64,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
|
5R01CA201496-03
|
$479,954
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-05
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
2018 Biomedical Engineering Society (BMES) Cellular and Molecular (CMBE) Conference
|
1R13EB025705-01
|
$3,000
|
|
CHAHINE, NADEEN
|
BIOMEDICAL ENGINEERING SOCIETY
|
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
5U24CA184407-06
|
$993,015
|
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-10
|
$368,325
|
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics
|
5U01CA214292-02
|
$685,690
|
|
TIEN, JOE
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Co-targeting oncogenic pathways in advanced prostate cancer
|
5R01CA198097-03
|
$381,212
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Transforming the diagnosis and care of patients with CTCL using TCR sequencing
|
5R01CA203721-03
|
$679,022
|
|
CLARK, RACHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
De-Regulation of 5hmC/TET2 Tumor Suppressor under Anti-Estrogen Therapy
|
5R01CA194302-03
|
$405,036
|
|
SHI, YUJIANG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum
|
5R44CA192588-04
|
$234,573
|
|
YANG, DERSHUNG
|
BRIGHTOUTCOME INC.
|
|
|
Clinical implementation of single cell tumor transcriptome analysis
|
5R33CA202820-03
|
$438,253
|
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
|
Integration of Clinical and Omic Data for Improved Prediction of Patient Outcome
|
1F32CA216937-01A1
|
$59,038
|
|
RUFFALO, MATTHEW
|
CARNEGIE-MELLON UNIVERSITY
|
|
|
Case/UHC Center for AIDS Research
|
5P30AI036219-24
|
$229,791
|
|
KARN, JONATHAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Overcoming resistance to first generation small molecule activators of PP2A.
|
1F30CA224977-01
|
$44,524
|
|
LEONARD, DANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers
|
1R01CA216579-01A1
|
$670,734
|
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations
|
5R01CA196643-03
|
$383,725
|
|
WANG, ZHENGHE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
High resolution volumetric MRI for prostate cancer active surveillance
|
5R01CA217098-02
|
$379,039
|
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
|
5R01CA206220-03
|
$547,857
|
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Omics Approach to Interrogating Mechanism of ETV5 in Glioma
|
5F31CA213926-02
|
$38,124
|
|
PARK, HANNAH
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Improving risk allocation and developing novel therapies for children with T-ALL
|
5R01CA193776-04
|
$594,741
|
|
TEACHEY, DAVID
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-15
|
$399,000
|
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
|
1R01CA219024-01A1
|
$123,772
|
|
FABBRI, MULLER
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
|
5R01CA212190-02
|
$374,232
|
$187,116
|
HARDY, KRISTINA
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers
|
5R01CA193549-04
|
$356,850
|
|
KOMUROV, KAKAJAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Patient Preferences and Adherence in Adolescents and Young Adults with Cancer
|
5K07CA200668-03
|
$144,855
|
|
MCGRADY, MEGHAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
5R01CA184090-04
|
$362,569
|
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Total relevant funding to Sleep Disorders for this search: $19,407,363
|
